biblio

Export 13 results:
Filters: Keyword is Antitubercular activity  [Clear All Filters]
Journal Article
N. C. Desai, Bhatt, K., Jadeja, D. J., Mehta, H. K., Khedkar, V. M., and Sarkar, D., “Conventional and microwave-assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids”, Drug Development Research, vol. 83, no. 2, pp. 416-431, 2022.
D. D. Subhedar, Shaikh, M. H., Nagargoje, A. A., Sarkar, D., Khedkar, V. M., and Shingate, B. B., “[DBUH][OAc]-catalyzed domino synthesis of novel benzimidazole incorporated 3,5-Bis (Arylidene)-4-piperidones as potential antitubercular agents”, Polycyclic Aromatic Compounds, vol. 42, no. 10, pp. 7010-7024, 2022.
T. S. Chitre, Patil, S. M., Sujalegaonkar, A. G., Asgaonkar, K. D., Khedkar, V. M., Garud, D. R., Jha, P. C., Gaikwad, S. Y., Kulkarni, S., Choudhari, A., and Sarkar, D., “Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives”, Current Computer-Aided Drug Design, vol. 15, no. 5, pp. 433-444, 2019.
R. A. Limaye, Kumbhar, V. B., Natu, A. D., Paradkar, M. V., Honmore, V. S., Chauhan, R. R., Gample, S. P., and Sarkar, D., “One pot solvent free synthesis and in vitro antitubercular screening of 3-aracylphthalides against mycobacterium tuberculosis”, Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 3, pp. 711-714, 2013.
M. Muthukrishnan, Mujahid, M., Yogeeswari, P., and Sriram, D., “Syntheses and biological evaluation of new triazole-spirochromone conjugates as inhibitors of mycobacterium tuberculosis”, Tetrahedron Letters, vol. 52, no. 18, pp. 2387-2389, 2011.
V. Shinde, Mahulikar, P., Mhaske, P. C., Chakraborty, S., Choudhari, A., Phalle, S., Choudhari, P., and Sarkar, D., “Synthesis and antimycobacterial evaluation of new 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives”, Medicinal Chemistry Research, vol. 28, no. 6, pp. 805-819, 2019.
M. Mujahid, Gonnade, R. G., Yogeeswari, P., Sriram, D., and Muthukrishnan, M., “Synthesis and antitubercular activity of amino alcohol fused spirochromone conjugates”, Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 5, pp. 1416-1419, 2013.
S. T. Dhumal, Deshmukh, A. R., Bhosle, M. R., Khedkar, V. M., Nawale, L. U., Sarkar, D., and Mane, R. A., “Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 15, pp. 3646-3651, 2016.
V. Shinde, Mahulikar, P., Mhaske, P. C., Nawale, L., and Sarkar, D., “Synthesis and biological evaluation of new 2-aryl-4-((4-aryl-1H-1,2,3-triazol-1-yl)methyl)thiazole derivatives”, Research on Chemical Intermediates, vol. 44, no. 2, pp. 1247-1260, 2018.
A. B. Danne, “Synthesis and biological evaluation of novel triazole-biscoumarin conjugates as potential antitubercular and anti-oxidant agents”, Research on Chemical Intermediates, vol. 44, no. 10, pp. 1-28, 2018.
N. C. Desai, Somani, H., Trivedi, A., Bhatt, K., Nawale, L., Khedkar, V. M., Jha, P. C., and Sarkar, D., “Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 7, pp. 1776-1783, 2016.
A. P. Chavan, Deshpande, R. R., Borade, N. A., Shinde, A., Mhaske, P. C., Sarkar, D., and Bobade, V. D., “Synthesis of new 1,3,4-oxadiazole and benzothiazolylthioether derivatives of 4-arylmethylidene-3-substituted-isoxazol-5(4H)-one as potential antimycobacterial agents”, Medicinal Chemistry Research, vol. 28, no. 11, pp. 1873-1884, 2019.
R. R. Joshi, Barchha, A., Khedkar, V. M., Pissurlenkar, R. R. S., Sarkar, S., Sarkar, D., Joshi, R. R., Joshi, R. A., Shah, A. K., and Coutinho, E. C., “Targeting dormant tuberculosis bacilli: results for molecules with a novel pyrimidone scaffold”, Chemical Biology & Drug Design, vol. 85, no. 2, pp. 201-207, 2015.